+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset



Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset



Clinical Medicine. Oncology 2: 481-486



In this article, we describe the treatment of long standing juvenile-onset recurrent respiratory papillomatosis (JORRP) with eventual transformation to carcinoma in a patient who lived to the age of 73. Treatment modalities consisted of bronchoscopy and local excision initially. Later, YAG and CO2 laser debulking were used. Radiotherapy, chemotherapy with carboplatin (300 mg/m2) and 5-FU (600 mg/m2), oral methotrexate (5-7.5 mg/week), pegylated Interferon, indole-3-carbamide, and intralesional cidofovir were also utilized in the treatment of this patient. Except for methotrexate, each of the treatment regimens used in this patient, initially decreased growth of the papillomas and improved symptoms experienced by the patient. Interestingly, we found that this patient's long standing JORRP initially responded to a chemotherapy regimen of 4 cycles of carboplatin (300 mg/m2) and 5-FU (600 mg/m2) as well. Ultimately, the disease became resistant to all forms of treatment and progressed. The patient eventually succumbed to the disease after an approximate 77 year course.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055418397

Download citation: RISBibTeXText

PMID: 21892322


Related references

Two cases of juvenile-onset and adult-onset recurrent respiratory papillomatosis. Nihon Kokyuki Gakkai Zasshi 49(9): 667-673, 2011

A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102(1): 9, 1992

Juvenile-onset recurrent respiratory papillomatosis. Advances in Oto-Rhino-Laryngology 73: 105-108, 2012

Juvenile-Onset Recurrent Respiratory Papillomatosis. Pediatric Asthma Allergy & Immunology 15(1): 59-62, 2001

Risk factors of juvenile onset recurrent respiratory papillomatosis in the lower respiratory tract. Chinese Medical Journal 125(19): 3496-3499, 2012

The cost of juvenile-onset recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 126(8): 935-939, 2000

Operative management of juvenile-onset recurrent respiratory papillomatosis. Operative Techniques in Otolaryngology-Head and Neck Surgery 23(2), 2012

Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatric Infectious Disease Journal 17(5): 372-376, 1998

Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis. Otolaryngologic Clinics of North America 33(1): 187-207, 2000

Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis. ArchivesofOtolaryngology--HeadandNeckSurgery136(1):7, 2010

Predictors of remission in juvenile-onset recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 129(12): 1275-1278, 2003

Clinical study of juvenile-onset recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Ke Za Zhi 36(6): 458-462, 2001

National registry for juvenile-onset recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 129(9): 976-982, 2003

Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Annals of Otology Rhinology and Laryngology 111(11): 957-961, 2002

Can zinc be an adjuvant therapy for juvenile onset recurrent respiratory papillomatosis?. International Journal of Pediatric Otorhinolaryngology 71(8): 1163-1173, 2007